Nishikiori, Hirotaka
Yama, Naoya
Hirota, Kenichi
Mori, Yuki
Neriai, Ippei
Takenaka, Haruka
Saito, Atsushi
Takahashi, Mamoru
Kuronuma, Koji
Ueda, Shinichiro
Hatakenaka, Masamitsu
Chiba, Hirofumi
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 11 September 2025
Accepted: 8 December 2025
First Online: 17 December 2025
Declarations
:
: This study was conducted in accordance with the ethical standards outlined in the Declaration of Helsinki and received approval from the ethics committee of the Sapporo Medical University School of Medicine (approval date, 28 October, 2020; approval number, 2–1–42). Written informed consent was obtained from all participants.
: Not applicable.
: This study was supported by Boehringer Ingelheim. The sponsor had no involvement in the study design, data analysis, or interpretation of results. Boehringer Ingelheim was permitted to review the manuscript to ensure medical and scientific accuracy concerning its substances and to assess any implications for intellectual property.HN, YM, and HC received research funding from Nippon Boehringer Ingelheim and M3, Inc. HN also received consulting fees from M3, Inc. HC received lecture and consulting fees from both Nippon Boehringer Ingelheim and M3, Inc. NY, KH, IN, HT, AS, MT, KK, and MH declare no conflicts of interest. None of the authors have any financial involvement in the sales of BMAX.